Libya’s healthcare system struggles amid ongoing instability

Libya’s healthcare system continues to face deep structural challenges, as corruption, weak oversight, and political fragmentation undermine efforts to reform the sector.

According to Libya Observer on April 15th, Libyan authorities have recently warned about the circulation of counterfeit medicines in the country, raising serious concerns about patient safety and the integrity of the national drug supply.

Health officials stressed the need for stricter controls and monitoring mechanisms to prevent the distribution of unsafe products and protect public health.

The issue of counterfeit drugs reflects broader systemic failures. As reported by Libya Observer on December 12th, investigations have highlighted significant gaps in inspection procedures and regulatory oversight, allowing even officially licensed medicines to enter the market without proper quality control.

These shortcomings point to a fragmented and poorly coordinated healthcare governance system.

This political and economic fragmentation lies at the root of many of the country’s challenges. However, some limited signs of change have begun to emerge.

On April 11th, the Central Bank of Libya (CBL) welcomed the signing of Annex No. 1 to the Unified Development Agreement.

The agreement represents a step toward unifying financial policy and strengthening public spending discipline, marking the first financial agreement between Libya’s polarised eastern and western administrations in over 13 years.

Efforts to reform the healthcare sector have been initiated but remain limited in effectiveness. On February 14th, Prime Minister Abdulhamid Dbeibah of the Government of National Unity launched a 100-day reform program to restructure what he described as the country’s “most problematic” sector.

As part of this initiative, authorities have conducted field inspections of key medical facilities in Tripoli to improve services and address long-standing inefficiencies.

Despite these efforts, Libya’s healthcare system continues to be widely described as one of the most dysfunctional sectors of the state.

Corruption plays a central role in undermining the system, affecting procurement processes, resource allocation, and service delivery.

Political divisions between rival administrations further complicate coordination, resulting in uneven access to healthcare across the country.

At the same time, foreign actors are increasingly stepping into this governance vacuum. Countries such as Italy have expanded their involvement through healthcare cooperation agreements, alongside broader economic and energy interests.

While such engagement can provide much-needed resources and expertise, it also reflects competing external agendas within Libya’s fragmented landscape.

These developments highlight a healthcare system under severe strain. The spread of counterfeit medicines, weak institutional oversight, and growing foreign involvement all point to a sector that remains deeply vulnerable.

Without comprehensive reform and stronger central coordination, Libya’s healthcare system is likely to remain fragile, leaving large segments of the population exposed to inadequate and potentially unsafe medical care.

Libya Observer and agencies, Maghrebi.org